First Installation at Hemas Hospital Wattala
DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert 630, revolutionizing non-invasive liver assessments. This innovative technology, which is acknowledged as the world standard for liver health management, improves the early identification, diagnosis, and ongoing monitoring of liver diseases, guaranteeing better patient care.
The first Echosens FibroScan® Expert 630 was successfully delivered by DIMO Healthcare to Hemas Hospital Wattala as part of this ground-breaking launch, assisting the hospital’s growth into a new liver center. In recognition of the company’s outstanding reputation in the healthcare sector and its steadfast dedication to providing exceptional after-sales service, Hemas Hospitals chose DIMO Healthcare as its trusted installation partner.
A very effective, non-invasive substitute for a typical liver biopsy, the Echosens FibroScan® Expert 630 greatly lowers expenses and complexity for patients as well as medical professionals. It allows for a painless exam to be performed in under 4 minutes by a trained operator. It is essential for screening and tracking liver diseases such as hepatitis, Metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD). Additionally, the device’s unique ability to measure spleen stiffness makes it possible to help manage and stratify patients with advanced chronic liver disease. Indeed, the measurement of spleen stiffness has been used in a clinical setting to assess portal hypertension and for variceal surveillance.
Furthermore, the device’s increased portal hypertension diagnostic capacity makes it easier to stratify patients with severe chronic liver disease for esophageal varices.